Allergen Recalls: How Co-Manufacturer Errors Cause Undeclared Allergen Contamination

Undeclared allergens remain one of the most common and preventable recall triggers in packaged foods. Despite meticulous sourcing and compliant labels, the failure point is often neither the ingredient nor the packaging. It’s the production floor.

Allergen control only works when it extends beyond documentation and into the day-to-day behaviors inside co-manufacturing and copacking facilities. As private label timelines accelerate and product lines multiply, even small lapses can create high-impact recalls.

This article breaks down the operational patterns behind allergen cross-contact, why they persist, and the production-level controls that consistently prevent them. See how we support production safety from the very beginning in Private Label Made Simple.

The Root Cause: Allergen Failures Start in the Manufacturing Process

Principle: Allergen control lives or dies in the execution, not the paperwork.

The majority of undeclared allergen recalls originate from floor-level missteps, not the spec sheet.
Four breakdowns appear repeatedly across FDA recall notices:

Shared equipment that isn’t fully sanitized
Formula changes that never make it into updated labels
Incorrect or inconsistent allergen statements
Ingredient substitutions during shortages without risk reassessment

These issues surface even in facilities with strong credentials. A label might say “no allergens present,” while the equipment and the residue on it tell a different story. We’ve seen it in cases like this where the product label showed one thing, but cross-contact told a different story.

Weak phrasing: “Sometimes sanitation issues cause cross-contact.”
Strong phrasing: “Cross-contact often traces back to incomplete sanitation between allergen and non-allergen runs, even in certified facilities.”

Real Example: Cross-Contact in High-Volume Snack Lines

Facilities producing nuts, seeds, and snack blends frequently run allergen-containing SKUs and allergen-free SKUs on the same line. When line clearance relies on visual checks instead of validated cleaning verification, traces remain. That trace becomes an undeclared allergen the moment it hits the next batch.

Prevention Starts Before the First Batch

Principle: Allergen protection is a pre-production discipline.

A brand’s best defense is visibility before ingredients arrive. That requires a clear understanding of a co-manufacturer’s sanitation, sequencing, documentation, and traceability systems.

Critical controls include:

Cleaning and changeover protocols between allergen and non-allergen products
Documented sanitation verification with ATP or allergen swabs
Dedicated lines for high-risk SKUs
Digital traceability systems that link batches, materials, and equipment use

Weak phrasing: “Ensure your coman has good cleaning processes.”
Strong phrasing: “Require written allergen changeover protocols with measurable verification steps before approving a production run.”

Example: Higher Risk in Large Batch Formats

Food-service and wholesale formats magnify the consequences of a missed control. Larger volume means more touchpoints, more surface area, and more opportunities for cross-contact.

Procurement Alone Can’t Protect Your Product

Principle: Ingredient purity does not guarantee finished-product safety.

Importers may provide allergen-free ingredients with verified documentation. Those controls collapse the instant ingredients enter a poorly managed production line.

Effective programs integrate procurement and production, ensuring the safety story continues across every step.

Key practices include:

Allergen statements linked to sourcing specs
Country-of-origin documents aligned with risk assessments
Procurement data flowing directly to QA and R&D
R&D formulas written with plant capabilities in mind

Weak phrasing: “Production issues can cause contamination.”
Strong phrasing: “Even flawlessly sourced ingredients become high-risk once they enter a line with undocumented sanitation gaps.”

Real Example: Industry Recalls That Followed System Failures

Recent undeclared allergen recalls show the same pattern: the system broke long before the product reached QA. Once cross-contact occurs on the floor, no level of documentation can undo it. We’ve seen what happens when these systems fail. Advance Food International’s pickle recall and Big Y Foods’ Salmonella issues are reminders that oversight costs more than just time.

Why Strong Co-Man Relationships Require Oversight

Principle: You may not own the facility, but you own the risk.

Brands are responsible for every finished-product claim, regardless of who produced it. That reality makes structured oversight essential.

Effective co-man governance typically includes:

Shared documentation platforms with approval checkpoints
Batch record review before and after production
On-site QA presence during allergen-sensitive runs
Contingency plans when a facility cannot meet spec or verification standards

Weak phrasing: “Work with your coman to ensure compliance.”
Strong phrasing: “Embed oversight into the coman relationship through mandatory batch documentation, sanitation proof, and traceable verification logs.”

Example: The Difference Between Confidence and Holds

Brands with embedded QA support release batches faster, respond to retailer inquiries immediatel,y and avoid long-term product holds. Brands without it face delays, uncertainty, and increased regulatory exposure.

Turning Safety Into a Built-In System

Strong allergen control protects brands at three levels: sourcing, manufacturing, and labeling. The earlier safety is embedded, the fewer downstream controls are needed. The later it enters, the more expensive it becomes.

A robust allergen program is not an add-on. It is the structure that holds the entire product line together. Explore how we’re helping brands navigate risk and raise the bar across the industry in our take on GFSI.

Partnering for Production Safety

At Source86, we help brands build food-safety foundations that travel with the product, from sourcing spec to sanitation protocol to final label claim. Whether developing new private label SKUs or scaling seasonal innovations, we support clients with:

Full-cycle sourcing
FSQA integration
Production oversight
R&D aligned to plant capability

If you’re seeing gaps in your coman relationships, production visibility, or allergen-control systems, there is a better way to operate.

Let’s build the right structure around your next run.